Cliff Asness’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-18,608
Closed -$1.3M 2985
2024
Q3
$1.3M Buy
18,608
+271
+1% +$18.6K ﹤0.01% 1725
2024
Q2
$1.23M Buy
18,337
+161
+0.9% +$10.8K ﹤0.01% 1659
2024
Q1
$1.25M Sell
18,176
-14,105
-44% -$952K ﹤0.01% 1597
2023
Q4
$2.01M Sell
32,281
-3,534
-10% -$198K ﹤0.01% 1342
2023
Q3
$2.01M Buy
35,815
+13,508
+61% +$760K ﹤0.01% 1323
2023
Q2
$1.13M Buy
22,307
+4,357
+24% +$232K ﹤0.01% 1502
2023
Q1
$979K Buy
17,950
+10,149
+130% +$593K ﹤0.01% 1558
2022
Q4
$488K Buy
+7,801
New +$518K ﹤0.01% 1822

Other funds holding AXNX

Cliff Asness's AXNX Position: Q4 2024 in Review

Cliff Asness sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 18,608 shares — an estimated $1.3M sold.

Cliff Asness first reported a position in AXNX in Q4 2022 and held it in 8 quarters. The position peaked at $2.01M in Q3 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Cliff Asness reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Cliff Asness sold 18,608 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $1.3M.
  • Cliff Asness first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 8 quarters.
  • Cliff Asness's Axonics, Inc. Common Stock position peaked at $2.01M in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on AQR Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.